Pelusi, Serena
Macchi, Chiara
Malvestiti, Francesco
Margarita, Sara
De Matteis, Irene
Periti, Giulia
Rondena, Jessica
Mira, Stefania
Iemma, Francesca
Tranchina, Martina
Nardi, Barbara
Lucci, Carla
Sirtori, Cesare R.
Millet, Oscar
Mato, Jose M.
Targher, Giovanni
Prati, Daniele
Ruscica, Massimiliano
Valenti, Luca
,
Pelusi, Serena
Periti, Giulia
Moretti, Vittoria
Mira, Stefania
Margarita, Sara
Ronzoni, Luisa
Marchelli, Daniele
Torgabehei, Hadi Heidgah
Cazzaniga, Alessandra
Sinopoli, Elena
Cerami, Laura
Casirati, Elia
Rrapaj, Eniada
Akkaldev, Divya
Malvestiti, Francesco
Tranchina, Martina
Ferrari, Francesca
Lamorte, Giuseppe
Vaira, Valentina
Prati, Daniele
Valenti, Luca
D’Ambrosio, Roberta
Tosetti, Giulia
Lampertico, Massimo Iavarone Pietro
Maggioni, Marco
Orsi, Emanuela
Cespiati, Annalisa
Dongiovanni, Paola
Fracanzani, Anna Ludovica
Rosso, Chiara
Armandi, Angelo
Caviglia, Gian Paolo
Bugianesi, Elisabetta
Pennisi, Grazia
Petta, Salvatore
Liguori, Antonio
Miele, Luca
Soardo, Giorgio
Russo, Francesco Paolo
Federico, Alessandro
Tavaglione, Federica
Vespasiani-Gentilucci, Umberto
Marchignoli, Francesca
Pironi, Loris
Pollicino, Teresa
Funding for this research was provided by:
Ministero dell'Università e della Ricerca
Ministry of Health, Italy (RF-2021-12373889,)
Horizon Europe (HORIZON-MISS-2021-CANCER-02-03)
Article History
Received: 1 August 2025
Accepted: 29 October 2025
First Online: 26 November 2025
Declarations
:
: The study was approved by the Ethical Committee of the Fondazione IRCCS Ca’ Granda, and each participant signed a written informed consent (ID 1650, revision June 23rd, 2020).
: N/A, see ethical consideration.
: None of the authors report any conflicts of interest relevant for the present manuscript. LV reports speaking fees from: Viatris, Novo Nordisk, GSK; consulting for: Novo Nordisk, Pfizer, Boehringer Ingelheim, Resalis, Almac. JMM reports speaking fees and consulting from Abbott.